// May 16, 2022
An all-too-familiar experience in recent years, medicines supply chain disruptions can arise from many factors, including pandemics like COVID-19, natural disasters, and geopolitical events like those taking place right now in Eastern Europe.
// May 13, 2022
As pharmaceutical continuous manufacturing (PCM) technology captures increasing stakeholder interest as one way to help achieve this goal, USP public quality standards and related programs will remain an essential part of the solution to support quality and innovation and bolster supply chain resilience.
// April 21, 2022
USP is proud to celebrate and honor the commitment and achievements of over 1,000 Expert Volunteers and Government Liaisons who make our work possible.
// March 11, 2022
The supply chain for medicines is complex and spans the globe – no government, organization, or company has all the solutions or capacity to strengthen the supply chain alone; perspectives, input, expertise, and resources from many sectors are needed.